Predominantly Antibody Deficiencies

  • Asghar Aghamohmmadi
  • Vassilios Lougaris
  • Alessandro Plebani
  • Toshio Miyawaki
  • Anne Durandy
  • Lennart Hammarström
  • Antibody deficiencies are the most common forms of primary immunodeficiency diseases, generally easily controlled by immunoglobulin substitution.

  • Some of antibody deficiencies could be secondary to a T cell deficiency that has to be intensively looked for, since it severely worsens the prognosis and modifies the treatment.

  • In the absence of early diagnosis and appropriate management, primary antibody deficiency can lead to serious morbidity and early mortality.

  • A diagnostic delay in affected patients with primary antibody deficiency still remains a significant problem due to limited awareness of their presenting features.

  • Clinical history is the most important aspect of suspecting a diagnosis of primary antibody deficiency.

  • Defining the molecular defect of antibody deficiencies is essential for accurate diagnosis, including prenatal diagnosis, and appropriate management of patients.


Allergy Clin Immunol Common Variable Immunodeficiency Primary Immunodeficiency Disease Antibody Deficiency Common Variable Immune Deficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    International Union of Immunological Societies (1999) Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. Clin Exp Immunol 118 Suppl 1: 1–28CrossRefGoogle Scholar
  2. 2.
    Agematsu K, Futatani T, Hokibara S, Kobayashi N, Takamoto M, Tsukada S, Suzuki H, Koyasu S, Miyawaki T, Sugane K, Komiyama A, Ochs HD (2002) Absence of memory B cells in patients with common variable immunodeficiency. Clin Immunol 103:34–42PubMedCrossRefGoogle Scholar
  3. 3.
    Aghamohammadi A, Farhoudi A, Moin M, Rezaei N, Kouhi A, Pourpak Z, Yaseri N, Movahedi M, Gharagozlou M, Zandieh F, Yazadni F, Arshi S, Mohammadzadeh I, Ghazi BM, Mahmoudi M, Tahaei S, Isaeian A (2005) Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency. Clin Diagn Lab Immunol 12:825–832PubMedGoogle Scholar
  4. 4.
    Aghamohammadi A, Fiorini M, Moin M, Parvaneh N, Teimourian S, Yeganeh M, Goffi F, Kanegane H, Amirzargar AA, Pourpak Z, Rezaei N, Salavati A, Pouladi N, Abdollahzade S, Notarangelo LD, Miyawaki T, Plebani A (2006) Clinical, immunological and molecular characteristics of 37 Iranian patients with X-linked agammaglobulinemia. Int Arch Allergy Immunol 141:408–414PubMedCrossRefGoogle Scholar
  5. 5.
    Aghamohammadi A, Kanegane H, Moein M, Farhoudi A, Pourpak Z, Movahedi M, Gharagozlou M, Zargar AA, Miyawaki T (2003) Identification of an SH2D1A mutation in a hypogammaglobulinemic male patient with a diagnosis of common variable immunodeficiency. Int J Hematol 78:45–47PubMedCrossRefGoogle Scholar
  6. 6.
    Aghamohammadi A, Moazzami K, Rezaei N, Karimi A, Movahedi M, Gharagozlou M, Abdollahzade S, Pouladi N, Kouhi A, Moin M (2008) ENT manifestations in Iranian patients with primary antibody deficiencies. J Laryngol Otol 122:409–413PubMedCrossRefGoogle Scholar
  7. 7.
    Aghamohammadi A, Moein M, Farhoudi A, Pourpak Z, Rezaei N, Abolmaali K, Movahedi M, Gharagozlou M, Ghazi BM, Mahmoudi M, Mansouri D, Arshi S, Trash NJ, Akbari H, Sherkat R, Hosayni RF, Hashemzadeh A, Mohammadzadeh I, Amin R, Kashef S, Alborzi A, Karimi A, Khazaei H (2002) Primary immunodeficiency in Iran: first report of the National Registry of PID in Children and Adults. J Clin Immunol 22:375–380PubMedCrossRefGoogle Scholar
  8. 8.
    Aghamohammadi A, Moin M, Farhoudi A, Rezaei N, Pourpak Z, Movahedi M, Gharagozlou M, Nabavi M, Shahrokhi A (2004) Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia. FEMS Immunol Med Microbiol 40:113–118PubMedCrossRefGoogle Scholar
  9. 9.
    Aghamohammadi A, Parvaneh N, Tirgari F, Mahjoob F, Movahedi M, Gharagozlou M, Mansouri M, Kouhi A, Rezaei N, Webster D (2006) Lymphoma of mucosa-associated lymphoid tissue in common variable immunodeficiency. Leuk Lymphoma 47:343–346PubMedCrossRefGoogle Scholar
  10. 10.
    Aittoniemi J, Koskinen S, Laippala P, Laine S, Miettinen A (1999) The significance of IgG subclasses and mannan-binding lectin (MBL) for susceptibility to infection in apparently healthy adults with IgA deficiency. Clin Exp Immunol 116:505–508PubMedCrossRefGoogle Scholar
  11. 11.
    al-Attas RA, Rahi AH (1998) Primary antibody deficiency in Arabs: first report from eastern Saudi Arabia. J Clin Immunol 18:368–371PubMedCrossRefGoogle Scholar
  12. 12.
    Ambrosino DM, Siber GR, Chilmonczyk BA, Jernberg JB, Finberg RW (1987) An immunodeficiency characterized by impaired antibody responses to polysaccharides. N Engl J Med 316:790–793PubMedGoogle Scholar
  13. 13.
    Ammann AJ, Hong R (1971) Selective IgA deficiency: presentation of 30 cases and a review of the literature. Medicine (Baltimore) 50:223–236CrossRefGoogle Scholar
  14. 14.
    Amoras AL, Kanegane H, Miyawaki T, Vilela MM (2003) Defective Fc-, CR1- and CR3-mediated monocyte phagocytosis and chemotaxis in common variable immunodeficiency and X-linked agammaglobulinemia patients. J Investig Allergol Clin Immunol 13:181–188PubMedGoogle Scholar
  15. 15.
    Andersen P, Permin H, Andersen V, Schejbel L, Garred P, Svejgaard A, Barington T (2005) Deficiency of somatic hypermutation of the antibody light chain is associated with increased frequency of severe respiratory tract infection in common variable immunodeficiency. Blood 105:511–517PubMedCrossRefGoogle Scholar
  16. 16.
    Ashman RF, Schaffer FM, Kemp JD, Yokoyama WM, Zhu ZB, Cooper MD, Volanakis JE (1992) Genetic and immunologic analysis of a family containing five patients with common-variable immune deficiency or selective IgA deficiency. J Clin Immunol 12:406–414PubMedCrossRefGoogle Scholar
  17. 17.
    Aspalter RM, Sewell WA, Dolman K, Farrant J, Webster AD (2000) Deficiency in circulating natural killer (NK) cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia. Clin Exp Immunol 121:506–514PubMedCrossRefGoogle Scholar
  18. 18.
    Aucouturier P, Bremard-Oury C, Griscelli C, Berthier M, Preud’homme JL (1987) Serum IgG subclass deficiency in ataxia-telangiectasia. Clin Exp Immunol 68:392–396PubMedGoogle Scholar
  19. 19.
    Aukrust P, Lien E, Kristoffersen AK, Muller F, Haug CJ, Espevik T, Froland SS (1996) Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency–possible immunologic and clinical consequences. Blood 87:674–681PubMedGoogle Scholar
  20. 20.
    Barlan IB, Geha RS, Schneider LC (1993) Therapy for patients with recurrent infections and low serum IgG3 levels. J Allergy Clin Immunol 92:353–355PubMedCrossRefGoogle Scholar
  21. 21.
    Bartmann P, Grosch-Worner I, Wahn V, Belohradsky BH (1991) IgG2 deficiency in children with human immunodeficiency virus infection. Eur J Pediatr 150:234–237PubMedCrossRefGoogle Scholar
  22. 22.
    Bates CA, Ellison MC, Lynch DA, Cool CD, Brown KK, Routes JM (2004) Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol 114:415–421PubMedCrossRefGoogle Scholar
  23. 23.
    Bayry J, Hermine O, Webster DA, Levy Y, Kaveri SV (2005) Common variable immunodeficiency: the immune system in chaos. Trends Mol Med 11:370–376PubMedCrossRefGoogle Scholar
  24. 24.
    Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Galicier L, Lepelletier Y, Webster D, Levy Y, Eibl MM, Oksenhendler E, Hermine O, Kaveri SV (2004) Common variable immunodeficiency is associated with defective functions of dendritic cells. Blood 104:2441–2443PubMedCrossRefGoogle Scholar
  25. 25.
    Bernier GM, Gunderman JR, Ruymann FB (1972) Kappa-chain deficiency. Blood 40:795–805PubMedGoogle Scholar
  26. 26.
    Berning AK, Eicher EM, Paul WE, Scher I (1980) Mapping of the X-linked immune deficiency mutation (xid) of CBA/N mice. J Immunol 124:1875–1877PubMedGoogle Scholar
  27. 27.
    Bjorkander J, Bake B, Hanson LA (1984) Primary hypogammaglobulinemia: impaired lung function and body growth with delayed diagnosis and inadequate treatment. Eur J Respir Dis 65:529–536PubMedGoogle Scholar
  28. 28.
    Bjorkander J, Bake B, Oxelius VA, Hanson LA (1985) Impaired lung function in patients with IgA deficiency and low levels of IgG2 or IgG3. N Engl J Med 313:720–724PubMedGoogle Scholar
  29. 29.
    Boncristiano M, Majolini MB, D’Elios MM, Pacini S, Valensin S, Ulivieri C, Amedei A, Falini B, Del Prete G, Telford JL, Baldari CT (2000) Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects. Eur J Immunol 30:2632–2638PubMedCrossRefGoogle Scholar
  30. 30.
    Bonhomme D, Hammarstrom L, Webster D, Chapel H, Hermine O, Le Deist F, Lepage E, Romeo PH, Levy Y (2000) Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency. J Immunol 165:4725–4730PubMedGoogle Scholar
  31. 31.
    Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, Kobrynski LJ, Levinson AI, Mazer B, Nelson RP, Jr., Orange JS, Routes JM, Shearer WT, Sorensen RU (2005) Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 94:S1–S63PubMedCrossRefGoogle Scholar
  32. 32.
    Bossuyt X, Moens L, Van Hoeyveld E, Jeurissen A, Bogaert G, Sauer K, Proesmans M, Raes M, De Boeck K (2007) Coexistence of (partial) immune defects and risk of recurrent respiratory infections. Clin Chem 53:124–130PubMedCrossRefGoogle Scholar
  33. 33.
    Bottaro A, Cariota U, de Lange GG, DeMarchi M, Gallina R, Oliviero S, Vlug A, Carbonara AO (1990) Multiple levels of analysis of an IGHG4 gene deletion. Hum Genet 86:191–197PubMedCrossRefGoogle Scholar
  34. 34.
    Boyle RJ, Le C, Balloch A, Tang ML (2006) The clinical syndrome of specific antibody deficiency in children. Clin Exp Immunol 146:486–492PubMedCrossRefGoogle Scholar
  35. 35.
    Braig DU, Schaffer AA, Glocker E, Salzer U, Warnatz K, Peter HH, Grimbacher B (2003) Linkage of autosomal dominant common variable immunodeficiency to chromosome 5p and evidence for locus heterogeneity. Hum Genet 112:369–378PubMedGoogle Scholar
  36. 36.
    Broides A, Yang W, Conley ME (2006) Genotype/phenotype correlations in X-linked agammaglobulinemia. Clin Immunol 118:195–200PubMedCrossRefGoogle Scholar
  37. 37.
    Brouet JC, Chedeville A, Fermand JP, Royer B (2000) Study of the B cell memory compartment in common variable immunodeficiency. Eur J Immunol 30:2516–2520PubMedCrossRefGoogle Scholar
  38. 38.
    Bruggemann M, Williams GT, Bindon CI, Clark MR, Walker MR, Jefferis R, Waldmann H, Neuberger MS (1987) Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med 166:1351–1361PubMedCrossRefGoogle Scholar
  39. 39.
    Brusco A, Saviozzi S, Cinque F, Bottaro A, DeMarchi M (1999) A recurrent breakpoint in the most common deletion of the Ig heavy chain locus (del A1-GP-G2–G4-E). J Immunol 163:4392–4398PubMedGoogle Scholar
  40. 40.
    Bruton OC (1952) Agammaglobulinemia. Pediatrics 9:722–728PubMedGoogle Scholar
  41. 41.
    Buckley RH (2002) Immunoglobulin G subclass deficiency: fact or fancy? Curr Allergy Asthma Rep 2:356–360PubMedCrossRefGoogle Scholar
  42. 42.
    Buckley RH (2004) Pulmonary complications of primary immunodeficiencies. Paediatr Respir Rev 5 Suppl A:S225–S233PubMedCrossRefGoogle Scholar
  43. 43.
    Buckley RH, Dees SC (1969) Correlation of milk precipitins with IgA deficiency. N Engl J Med 281:465–469PubMedCrossRefGoogle Scholar
  44. 44.
    Buckley RH, Schiff RI (1991) The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med 325:110–117PubMedGoogle Scholar
  45. 45.
    Burrows PD, Cooper MD (1997) IgA deficiency. Adv Immunol 65:245–276PubMedCrossRefGoogle Scholar
  46. 46.
    Busse PJ, Razvi S, Cunningham-Rundles C (2002) Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 109:1001–1004PubMedCrossRefGoogle Scholar
  47. 47.
    Cambronero R, Sewell WA, North ME, Webster AD, Farrant J (2000) Up-regulation of IL-12 in monocytes: a fundamental defect in common variable immunodeficiency. J Immunol 164:488–494PubMedGoogle Scholar
  48. 48.
    Cano F, Mayo DR, Ballow M (1990) Absent specific viral antibodies in patients with transient hypogammaglobulinemia of infancy. J Allergy Clin Immunol 85:510–513PubMedCrossRefGoogle Scholar
  49. 49.
    Carsetti R, Rosado MM, Donnanno S, Guazzi V, Soresina A, Meini A, Plebani A, Aiuti F, Quinti I (2005) The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol 115:412–417PubMedCrossRefGoogle Scholar
  50. 50.
    Carvalho Neves Forte W, Ferreira De Carvalho Junior F, Damaceno N, Vidal Perez F, Gonzales Lopes C, Mastroti RA (2000) Evolution of IgA deficiency to IgG subclass deficiency and common variable immunodeficiency. Allergol Immunopathol (Madr) 28:18–20Google Scholar
  51. 51.
    Casellas R, Nussenzweig A, Wuerffel R, Pelanda R, Reichlin A, Suh H, Qin XF, Besmer E, Kenter A, Rajewsky K, Nussenzweig MC (1998) Ku80 is required for immunoglobulin isotype switching. EMBO J 17:2404–2411PubMedCrossRefGoogle Scholar
  52. 52.
    Castigli E, Wilson SA, Garibyan L, Rachid R, Bonilla F, Schneider L, Geha RS (2005) TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 37:829–834PubMedCrossRefGoogle Scholar
  53. 53.
    Castigli E, Wilson SA, Scott S, Dedeoglu F, Xu S, Lam KP, Bram RJ, Jabara H, Geha RS (2005) TACI and BAFF-R mediate isotype switching in B cells. J Exp Med 201:35–39PubMedCrossRefGoogle Scholar
  54. 54.
    Catalan N, Selz F, Imai K, Revy P, Fischer A, Durandy A (2003) The block in immunoglobulin class switch recombination caused by activation-induced cytidine deaminase deficiency occurs prior to the generation of DNA double strand breaks in switch mu region. J Immunol 171:2504–2509PubMedGoogle Scholar
  55. 55.
    Chaudhuri J, Alt FW (2004) Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat Rev Immunol 4:541–552PubMedCrossRefGoogle Scholar
  56. 56.
    Chaudhuri J, Tian M, Khuong C, Chua K, Pinaud E, Alt FW (2003) Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422:726–730PubMedCrossRefGoogle Scholar
  57. 57.
    Conley ME (2002) Early defects in B cell development. Curr Opin Allergy Clin Immunol 2:517–522PubMedCrossRefGoogle Scholar
  58. 58.
    Conley ME, Notarangelo LD, Etzioni A (1999) Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 93:190–197PubMedCrossRefGoogle Scholar
  59. 59.
    Cucca F, Zhu ZB, Khanna A, Cossu F, Congia M, Badiali M, Lampis R, Frau F, De Virgiliis S, Cao A, Arnone M, Piras P, Campbell RD, Cooper MD, Volanakis JE, Powis SH (1998) Evaluation of IgA deficiency in Sardinians indicates a susceptibility gene is encoded within the HLA class III region. Clin Exp Immunol 111:76–80PubMedCrossRefGoogle Scholar
  60. 60.
    Cunningham-Rundles C (2001) Physiology of IgA and IgA deficiency. J Clin Immunol 21:303–309PubMedCrossRefGoogle Scholar
  61. 61.
    Cunningham-Rundles C (2004) Selective IgA deficiency. In: Stiehm ER, Ochs HD, Winkelstein JA (eds) Immunologic Disorders in Infants and Children. Elsevier Saunders, Philadelphia, pp 427–446Google Scholar
  62. 62.
    Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34–48PubMedCrossRefGoogle Scholar
  63. 63.
    Cunningham-Rundles C, Brandeis WE, Good RA, Day NK (1978) Milk precipitins, circulating immune complexes, and IgA deficiency. Proc Natl Acad Sci U S A 75:3387–3389PubMedCrossRefGoogle Scholar
  64. 64.
    Cunningham-Rundles C, Brandeis WE, Good RA, Day NK (1979) Bovine antigens and the formation of circulating immune complexes in selective immunoglobulin A deficiency. J Clin Invest 64:272–279PubMedCrossRefGoogle Scholar
  65. 65.
    Cunningham-Rundles C, Lieberman P, Hellman G, Chaganti RS (1991) Non-Hodgkin lymphoma in common variable immunodeficiency. Am J Hematol 37:69–74PubMedCrossRefGoogle Scholar
  66. 66.
    Cunningham-Rundles C, Radigan L (2005) Deficient IL-12 and dendritic cell function in common variable immune deficiency. Clin Immunol 115:147–153PubMedCrossRefGoogle Scholar
  67. 67.
    Cunningham-Rundles C, Radigan L, Knight AK, Zhang L, Bauer L, Nakazawa A (2006) TLR9 activation is defective in common variable immune deficiency. J Immunol 176:1978–1987PubMedGoogle Scholar
  68. 68.
    Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, Lieberman P (1987) Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol 7:294–299PubMedCrossRefGoogle Scholar
  69. 69.
    Cunningham-Rundles C, Zhou Z, Mankarious S, Courter S (1993) Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodies. J Clin Immunol 13:272–278PubMedCrossRefGoogle Scholar
  70. 70.
    Daele J, Zicot AF (2000) Humoral immunodeficiency in recurrent upper respiratory tract infections. Some basic, clinical and therapeutic features. Acta Otorhinolaryngol Belg 54:373–390PubMedGoogle Scholar
  71. 71.
    Dalal I, Reid B, Nisbet-Brown E, Roifman CM (1998) The outcome of patients with hypogammaglobulinemia in infancy and early childhood. J Pediatr 133:144–146PubMedCrossRefGoogle Scholar
  72. 72.
    Dalal I, Roifman CH (2006) Transient hypogammaglobulinemia of infancy, Accessed at:
  73. 73.
    Daly KA, Giebink GS, Lindgren B, Margolis RH, Westover D, Hunter LL, Le CT, Buran D (1995) Randomized trial of the efficacy of trimethoprim-sulfamethoxazole and prednisone in preventing post-tympanostomy tube morbidity. Pediatr Infect Dis J 14:1068–1074PubMedCrossRefGoogle Scholar
  74. 74.
    Dangl JL, Wensel TG, Morrison SL, Stryer L, Herzenberg LA, Oi VT (1988) Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J 7:1989–1994PubMedGoogle Scholar
  75. 75.
    Darragh PM (1982) The prevalence and prevention of severe mental handicap in Northern Ireland. Ir Med J 75:16–19PubMedGoogle Scholar
  76. 76.
    Davies CW, Juniper MC, Gray W, Gleeson FV, Chapel HM, Davies RJ (2000) Lymphoid interstitial pneumonitis associated with common variable hypogammaglobulinemia treated with cyclosporin A. Thorax 55:88–90PubMedCrossRefGoogle Scholar
  77. 77.
    Day N, Tangsinmankong N, Ochs H, Rucker R, Picard C, Casanova JL, Haraguchi S, Good R (2004) Interleukin receptor-associated kinase (IRAK-4) deficiency associated with bacterial infections and failure to sustain antibody responses. J Pediatr 144:524–526PubMedCrossRefGoogle Scholar
  78. 78.
    De Diego JI, Prim MP, Alfonso C, Sastre N, Rabanal I, Gavilan J (2001) Comparison of amoxicillin and azithromycin in the prevention of recurrent acute otitis media. Int J Pediatr Otorhinolaryngol 58:47–51PubMedCrossRefGoogle Scholar
  79. 79.
    De La Concha EG, Fernandez-Arquero M, Martinez A, Vidal F, Vigil P, Conejero L, Garcia-Rodriguez MC, Fontan G (1999) HLA class II homozygosity confers susceptibility to common variable immunodeficiency (CVID). Clin Exp Immunol 116:516–520PubMedCrossRefGoogle Scholar
  80. 80.
    De Vera MJ, Al-Harthi L, Gewurz AT (2004) Assessing thymopoiesis in patients with common variable immunodeficiency as measured by T cell receptor excision circles. Ann Allergy Asthma Immunol 93:478–484PubMedCrossRefGoogle Scholar
  81. 81.
    Deshayes F, Lapree G, Portier A, Richard Y, Pencalet P, Mahieu-Caputo D, Horellou P, Tsapis A (2004) Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor. Oncogene 23:3005–3012PubMedCrossRefGoogle Scholar
  82. 82.
    Di Noia J, Neuberger MS (2002) Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419:43–48PubMedCrossRefGoogle Scholar
  83. 83.
    Dobbs AK, Yang T, Farmer D, Kager L, Parolini O, Conley ME (2007) Cutting edge: a hypomorphic mutation in Igbeta (CD79b) in a patient with immunodeficiency and a leaky defect in B cell development. J Immunol 179:2055–2059PubMedGoogle Scholar
  84. 84.
    Dudley DD, Chaudhuri J, Bassing CH, Alt FW (2005) Mechanism and control of V(D) J recombination versus class switch recombination: similarities and differences. Adv Immunol 86:43–112PubMedCrossRefGoogle Scholar
  85. 85.
    Durandy A, Hivroz C, Mazerolles F, Schiff C, Bernard F, Jouanguy E, Revy P, DiSanto JP, Gauchat JF, Bonnefoy JY, Casanova JL, Fischer A (1997) Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression. J Immunol 158:2576–2584PubMedGoogle Scholar
  86. 86.
    Durandy A, Peron S, Fischer A (2006) Hyper-IgM syndromes. Curr Opin Rheumatol 18:369–376PubMedCrossRefGoogle Scholar
  87. 87.
    Durandy A, Peron S, Taubenheim N, Fischer A (2006) Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants. Hum Mutat 27:1185–1191PubMedCrossRefGoogle Scholar
  88. 88.
    Durandy A, Revy P, Fischer A (2004) Human models of inherited immunoglobulin class switch recombination and somatic hypermutation defects (hyper-IgM syndromes). Adv Immunol 82:295–330PubMedCrossRefGoogle Scholar
  89. 89.
    Durandy A, Revy P, Imai K, Fischer A (2005) Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects. Immunol Rev 203:67–79PubMedCrossRefGoogle Scholar
  90. 90.
    Durandy A, Taubenheim N, Peron S, Fischer A (2007) Pathophysiology of B cell intrinsic immunoglobulin class switch recombination deficiencies. Adv Immunol 94:275–306PubMedCrossRefGoogle Scholar
  91. 91.
    Edwards E, Razvi S, Cunningham-Rundles C (2004) IgA deficiency: clinical correlates and responses to pneumococcal vaccine. Clin Immunol 111:93–97PubMedCrossRefGoogle Scholar
  92. 92.
    Epstein MM, Gruskay F (1995) Selective deficiency in pneumococcal antibody response in children with recurrent infections. Ann Allergy Asthma Immunol 75:125–131PubMedGoogle Scholar
  93. 93.
    Espanol T, Catala M, Hernandez M, Caragol I, Bertran JM (1996) Development of a common variable immunodeficiency in IgA-deficient patients. Clin Immunol Immunopathol 80:333–335PubMedCrossRefGoogle Scholar
  94. 94.
    Fagarasan S, Kinoshita K, Muramatsu M, Ikuta K, Honjo T (2001) In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature 413:639–643PubMedCrossRefGoogle Scholar
  95. 95.
    Fasano MB, Sullivan KE, Sarpong SB, Wood RA, Jones SM, Johns CJ, Lederman HM, Bykowsky MJ, Greene JM, Winkelstein JA (1996) Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine (Baltimore) 75:251–261CrossRefGoogle Scholar
  96. 96.
    Fasth A (1982) Primary immunodeficiency disorders in Sweden: cases among children, 1974–1979. J Clin Immunol 2:86–92PubMedCrossRefGoogle Scholar
  97. 97.
    Fasth A, Nystrom J (2007) Safety and efficacy of subcutaneous human immunoglobulin in children with primary immunodeficiency. Acta Paediatr 96:1474–1478PubMedCrossRefGoogle Scholar
  98. 98.
    Ferrari S, Lougaris V, Caraffi S, Zuntini R, Yang J, Soresina A, Meini A, Cazzola G, Rossi C, Reth M, Plebani A (2007) Mutations of the Igbeta gene cause agammaglobulinemia in man. J Exp Med 204:2047–2051PubMedCrossRefGoogle Scholar
  99. 99.
    Ferrari S, Zuntini R, Lougaris V, Soresina A, Sourkova V, Fiorini M, Martino S, Rossi P, Pietrogrande MC, Martire B, Spadaro G, Cardinale F, Cossu F, Pierani P, Quinti I, Rossi C, Plebani A (2007) Molecular analysis of the pre-BCR complex in a large cohort of patients affected by autosomal-recessive agammaglobulinemia. Genes Immun 8:325–333PubMedCrossRefGoogle Scholar
  100. 100.
    Filipovich AH, Mathur A, Kamat D, Kersey JH, Shapiro RS (1994) Lymphoproliferative disorders and other tumors complicating immunodeficiencies. Immunodeficiency 5:91–112PubMedGoogle Scholar
  101. 101.
    French MA, Denis KA, Dawkins R, Peter JB (1995) Severity of infections in IgA deficiency: correlation with decreased serum antibodies to pneumococcal polysaccharides and decreased serum IgG2 and/or IgG4. Clin Exp Immunol 100:47–53PubMedCrossRefGoogle Scholar
  102. 102.
    Garibyan L, Lobito AA, Siegel RM, Call ME, Wucherpfennig KW, Geha RS (2007) Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID). J Clin Invest 117:1550–1557PubMedCrossRefGoogle Scholar
  103. 103.
    Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J (2007) Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 120:776–794PubMedCrossRefGoogle Scholar
  104. 104.
    Gitlin D, Janeway CA (1956) Agammaglobulinemia, congenital, acquired and transient forms. Prog Hematol 1:318–329PubMedGoogle Scholar
  105. 105.
    Goldacker S, Warnatz K (2005) Tackling the heterogeneity of CVID. Curr Opin Allergy Clin Immunol 5:504–509PubMedCrossRefGoogle Scholar
  106. 106.
    Granoff DM, Shackelford PG, Pandey JP, Boies EG (1986) Antibody responses to Haemophilus influenzae type b polysaccharide vaccine in relation to Km(1) and G2m(23) immunoglobulin allotypes. J Infect Dis 154:257–264PubMedGoogle Scholar
  107. 107.
    Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Drager R, Eibel H, Fischer B, Schaffer AA, Mages HW, Kroczek RA, Peter HH (2003) Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 4:261–268PubMedCrossRefGoogle Scholar
  108. 108.
    Gross JA, Dillon SR, Mudri S, Johnston J, Littau A, Roque R, Rixon M, Schou O, Foley KP, Haugen H, McMillen S, Waggie K, Schreckhise RW, Shoemaker K, Vu T, Moore M, Grossman A, Clegg CH (2001) TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity 15:289–302PubMedCrossRefGoogle Scholar
  109. 109.
    Gulbranson-Judge A, Tybulewicz VL, Walters AE, Toellner KM, MacLennan IC, Turner M (1999) Defective immunoglobulin class switching in Vav-deficient mice is attributable to compromised T cell help. Eur J Immunol 29:477–487PubMedCrossRefGoogle Scholar
  110. 110.
    Gustafson R, Gardulf A, Granert C, Hansen S, Hammarstrom L (1997) Prophylactic therapy for selective IgA deficiency. Lancet 350:865PubMedCrossRefGoogle Scholar
  111. 111.
    Gutierrez MG, Kirkpatrick CH (1997) Progressive immunodeficiency in a patient with IgA deficiency. Ann Allergy Asthma Immunol 79:297–301PubMedCrossRefGoogle Scholar
  112. 112.
    Hammarstrom L, Vorechovsky I, Webster D (2000) Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 120:225–231PubMedCrossRefGoogle Scholar
  113. 113.
    Hanson LA, Bjorkander J, Carlsson B, Roberton D, Soderstrom T (1988) The heterogeneity of IgA deficiency. J Clin Immunol 8:159–162PubMedCrossRefGoogle Scholar
  114. 114.
    Heneghan MA, Stevens FM, Cryan EM, Warner RH, McCarthy CF (1997) Celiac sprue and immunodeficiency states: a 25-year review. J Clin Gastroenterol 25:421–425PubMedCrossRefGoogle Scholar
  115. 115.
    Hermaszewski RA, Webster AD (1993) Primary hypogammaglobulinemia: a survey of clinical manifestations and complications. Q J Med 86:31–42PubMedGoogle Scholar
  116. 116.
    Herrod HG (1997) Follow-up of pediatric patients with recurrent infection and mild serologic immune abnormalities. Ann Allergy Asthma Immunol 79:460–464PubMedCrossRefGoogle Scholar
  117. 117.
    Hidalgo H, Moore C, Leiva LE, Sorensen RU (1996) Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections. Ann Allergy Asthma Immunol 76:341–346PubMedCrossRefGoogle Scholar
  118. 118.
    Holm AM, Aukrust P, Damas JK, Muller F, Halvorsen B, Froland SS (2005) Abnormal interleukin-7 function in common variable immunodeficiency. Blood 105:2887–2890PubMedCrossRefGoogle Scholar
  119. 119.
    Holm AM, Sivertsen EA, Tunheim SH, Haug T, Bjerkeli V, Yndestad A, Aukrust P, Froland SS (2004) Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells. Clin Exp Immunol 138:278–289PubMedCrossRefGoogle Scholar
  120. 120.
    Howard V, Myers LA, Williams DA, Wheeler G, Turner EV, Cunningham JM, Conley ME (2003) Stem cell transplants for patients with X-linked agammaglobulinemia. Clin Immunol 107:98–102PubMedCrossRefGoogle Scholar
  121. 121.
    Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, Kroczek RA (1999) ICOS is an inducible T cell co-stimulator structurally and functionally related to CD28. Nature 397:263–266PubMedCrossRefGoogle Scholar
  122. 122.
    Imai K, Catalan N, Plebani A, Marodi L, Sanal O, Kumaki S, Nagendran V, Wood P, Glastre C, Sarrot-Reynauld F, Hermine O, Forveille M, Revy P, Fischer A, Durandy A (2003) Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. J Clin Invest 112:136–142PubMedGoogle Scholar
  123. 123.
    Imai K, Slupphaug G, Lee WI, Revy P, Nonoyama S, Catalan N, Yel L, Forveille M, Kavli B, Krokan HE, Ochs HD, Fischer A, Durandy A (2003) Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol 4:1023–1028PubMedCrossRefGoogle Scholar
  124. 124.
    Imai K, Zhu Y, Revy P, Morio T, Mizutani S, Fischer A, Nonoyama S, Durandy A (2005) Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2. Clin Immunol 115:277–285PubMedCrossRefGoogle Scholar
  125. 125.
    Isgro A, Marziali M, Mezzaroma I, Luzi G, Mazzone AM, Guazzi V, Andolfi G, Cassani B, Aiuti A, Aiuti F (2005) Bone marrow clonogenic capability, cytokine production, and thymic output in patients with common variable immunodeficiency. J Immunol 174:5074–5081PubMedGoogle Scholar
  126. 126.
    Ishizaka A, Nakanishi M, Yamada S, Sakiyama Y, Matsumoto S (1989) Development of hypogammaglobulinemia in a patient with common variable immunodeficiency. Eur J Pediatr 149:175–176PubMedCrossRefGoogle Scholar
  127. 127.
    Islam KB, Baskin B, Nilsson L, Hammarstrom L, Sideras P, Smith CI (1994) Molecular analysis of IgA deficiency. Evidence for impaired switching to IgA. J Immunol 152:1442–1452PubMedGoogle Scholar
  128. 128.
    Janeway CA, Apt L, Gitlin D (1953) Agammaglobulinemia. Trans Assoc Am Physicians 66:200–202PubMedGoogle Scholar
  129. 129.
    Javier FC, 3rd, Moore CM, Sorensen RU (2000) Distribution of primary immunodeficiency diseases diagnosed in a pediatric tertiary hospital. Ann Allergy Asthma Immunol 84:25–30PubMedCrossRefGoogle Scholar
  130. 130.
    Johnson ML, Keeton LG, Zhu ZB, Volanakis JE, Cooper MD, Schroeder HW, Jr. (1997) Age-related changes in serum immunoglobulins in patients with familial IgA deficiency and common variable immunodeficiency (CVID). Clin Exp Immunol 108:477–483PubMedCrossRefGoogle Scholar
  131. 131.
    Kainulainen L, Nikoskelainen J, Vuorinen T, Tevola K, Liippo K, Ruuskanen O (1999) Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia. Am J Respir Crit Care Med 159:1199–1204PubMedGoogle Scholar
  132. 132.
    Kainulainen L, Varpula M, Liippo K, Svedstrom E, Nikoskelainen J, Ruuskanen O (1999) Pulmonary abnormalities in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol 104:1031–1036PubMedCrossRefGoogle Scholar
  133. 133.
    Kalfa VC, Roberts RL, Stiehm ER (2003) The syndrome of chronic mucocutaneous candidiasis with selective antibody deficiency. Ann Allergy Asthma Immunol 90:259–264PubMedCrossRefGoogle Scholar
  134. 134.
    Kanegane H, Taneichi H, Nomura K, Futatani T, Miyawaki T (2005) Severe neutropenia in Japanese patients with x-linked agammaglobulinemia. J Clin Immunol 25:491–495PubMedCrossRefGoogle Scholar
  135. 135.
    Kanegane H, Tsukada S, Iwata T, Futatani T, Nomura K, Yamamoto J, Yoshida T, Agematsu K, Komiyama A, Miyawaki T (2000) Detection of Bruton’s tyrosine kinase mutations in hypogammaglobulinaemic males registered as common variable immunodeficiency (CVID) in the Japanese Immunodeficiency Registry. Clin Exp Immunol 120:512–517PubMedCrossRefGoogle Scholar
  136. 136.
    Kanoh T, Mizumoto T, Yasuda N, Koya M, Ohno Y, Uchino H, Yoshimura K, Ohkubo Y, Yamaguchi H (1986) Selective IgA deficiency in Japanese blood donors: frequency and statistical analysis. Vox Sang 50:81–86PubMedCrossRefGoogle Scholar
  137. 137.
    Kavli B, Andersen S, Otterlei M, Liabakk NB, Imai K, Fischer A, Durandy A, Krokan HE, Slupphaug G (2005) B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil. J Exp Med 201:2011–2021PubMedCrossRefGoogle Scholar
  138. 138.
    Kilic SS, Tezcan I, Sanal O, Metin A, Ersoy F (2000) Transient hypogammaglobulinemia of infancy: clinical and immunologic features of 40 new cases. Pediatr Int 42:647–650PubMedCrossRefGoogle Scholar
  139. 139.
    Kinlen LJ, Webster AD, Bird AG, Haile R, Peto J, Soothill JF, Thompson RA (1985) Prospective study of cancer in patients with hypogammaglobulinemia. Lancet 1:263–266PubMedCrossRefGoogle Scholar
  140. 140.
    Knerr V, Grimbacher B (2007) Primary immunodeficiency registries. Curr Opin Allergy Clin Immunol 7:475–480PubMedCrossRefGoogle Scholar
  141. 141.
    Knight AK, Cunningham-Rundles C (2006) Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun Rev 5:156–159PubMedCrossRefGoogle Scholar
  142. 142.
    Ko J, Radigan L, Cunningham-Rundles C (2005) Immune competence and switched memory B cells in common variable immunodeficiency. Clin Immunol 116:37–41PubMedCrossRefGoogle Scholar
  143. 143.
    Kokron CM, Errante PR, Barros MT, Baracho GV, Camargo MM, Kalil J, Rizzo LV (2004) Clinical and laboratory aspects of common variable immunodeficiency. An Acad Bras Cienc 76:707–726PubMedGoogle Scholar
  144. 144.
    Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA (1993) Defective expression of T cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539–541PubMedCrossRefGoogle Scholar
  145. 145.
    Kosnik EF, Johnson JP, Rennels MB, Caniano DA (1986) Streptococcal sepsis presenting as acute abdomen in a child with transient hypogammaglobulinemia of infancy. J Pediatr Surg 21:975–976PubMedCrossRefGoogle Scholar
  146. 146.
    Koss MN, Hochholzer L, Langloss JM, Wehunt WD, Lazarus AA (1987) Lymphoid interstitial pneumonia: clinicopathological and immunopathological findings in 18 cases. Pathology 19:178–185PubMedCrossRefGoogle Scholar
  147. 147.
    Kowalczyk D, Mytar B, Zembala M (1997) Cytokine production in transient hypogammaglobulinemia and isolated IgA deficiency. J Allergy Clin Immunol 100:556–562PubMedCrossRefGoogle Scholar
  148. 148.
    Kralovicova J, Hammarstrom L, Plebani A, Webster AD, Vorechovsky I (2003) Fine-scale mapping at IGAD1 and genome-wide genetic linkage analysis implicate HLA-DQ/DR as a major susceptibility locus in selective IgA deficiency and common variable immunodeficiency. J Immunol 170:2765–2775PubMedGoogle Scholar
  149. 149.
    Kristinsson VH, Kristinsson JR, Jonmundsson GK, Jonsson OG, Thorsson AV, Haraldsson A (2001) Immunoglobulin class and subclass concentrations after treatment of childhood leukemia. Pediatr Hematol Oncol 18:167–172PubMedCrossRefGoogle Scholar
  150. 150.
    Lacombe C, Aucouturier P, Preud’homme JL (1997) Selective IgG1 deficiency. Clin Immunol Immunopathol 84:194–201PubMedCrossRefGoogle Scholar
  151. 151.
    Landesman SH, Schiffman G (1981) Assessment of the antibody response to pneumococcal vaccine in high-risk populations. Rev Infect Dis 3 Suppl: S184–S197PubMedGoogle Scholar
  152. 152.
    Laschinger C, Shepherd FA, Naylor DH (1984) Anti-IgA-mediated transfusion reactions in Canada. Can Med Assoc J 130:141–144PubMedGoogle Scholar
  153. 153.
    Lawrence EM, Edwards KM, Schiffman G, Thompson JM, Vaughn WK, Wright PF (1983) Pneumococcal vaccine in normal children. Primary and secondary vaccination. Am J Dis Child 137:846–850PubMedGoogle Scholar
  154. 154.
    Lederman HM, Winkelstein JA (1985) X-linked agammaglobulinemia: an analysis of 96 patients. Medicine (Baltimore) 64:145–156Google Scholar
  155. 155.
    Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD (2005) Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 105:1881–1890PubMedCrossRefGoogle Scholar
  156. 156.
    Lemmon JK, Knutsen AP (2006) Clinical manifestations, diagnosis and treatment of IgG subclass deficiency, Accessed at:
  157. 157.
    Lilic D, Sewell WA (2001) IgA deficiency: what we should-or should not-be doing. J Clin Pathol 54:337–338PubMedCrossRefGoogle Scholar
  158. 158.
    Lin MT, Chien YH, Shyur SD, Huang LH, Chiang YC, Wen DC, Liang PH, Yang HC (2006) De novo mutation in the BTK gene of atypical X-linked agammaglobulinemia in a patient with recurrent pyoderma. Ann Allergy Asthma Immunol 96:744–748PubMedCrossRefGoogle Scholar
  159. 159.
    Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, Cerutti A (2002) DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 3:822–829PubMedCrossRefGoogle Scholar
  160. 160.
    Litzman J, Burianova M, Thon V, Lokaj J (1996) Progression of selective IgA deficiency to common variable immunodeficiency in a 16 year old boy. Allergol Immunopathol (Madr) 24:174–176Google Scholar
  161. 161.
    Liu AJ, Dao-Ung LP, McDonald D, Nanan R (2006) Chronic gingivitis in a new BTK mutation. Eur J Haematol 76:171–175PubMedCrossRefGoogle Scholar
  162. 162.
    Liu GB, Yan H, Jiang YF, Chen R, Pettigrew JD, Zhao KN (2005) The properties of CpG islands in the putative promoter regions of human immunoglobulin (Ig) genes. Gene 358:127–138PubMedCrossRefGoogle Scholar
  163. 163.
    Lopez-Granados E, Perez de Diego R, Ferreira Cerdan A, Fontan Casariego G, Garcia Rodriguez MC (2005) A genotype-phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemia. J Allergy Clin Immunol 116:690–697PubMedCrossRefGoogle Scholar
  164. 164.
    Losi CG, Silini A, Fiorini C, Soresina A, Meini A, Ferrari S, Notarangelo LD, Lougaris V, Plebani A (2005) Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency. J Clin Immunol 25:496–502PubMedCrossRefGoogle Scholar
  165. 165.
    Luzi G, Businco L, Aiuti F (1983) Primary immunodeficiency syndromes in Italy: a report of the national register in children and adults. J Clin Immunol 3:316–320PubMedCrossRefGoogle Scholar
  166. 166.
    Mackay F, Kalled SL (2002) TNF ligands and receptors in autoimmunity: an update. Curr Opin Immunol 14:783–790PubMedCrossRefGoogle Scholar
  167. 167.
    Mackay F, Schneider P, Rennert P, Browning J (2003) BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol 21:231–264PubMedCrossRefGoogle Scholar
  168. 168.
    Maguire GA, Kumararatne DS, Joyce HJ (2002) Are there any clinical indications for measuring IgG subclasses? Ann Clin Biochem 39:374–377PubMedCrossRefGoogle Scholar
  169. 169.
    Manis JP, Gu Y, Lansford R, Sonoda E, Ferrini R, Davidson L, Rajewsky K, Alt FW (1998) Ku70 is required for late B cell development and immunoglobulin heavy chain class switching. J Exp Med 187:2081–2089PubMedCrossRefGoogle Scholar
  170. 170.
    Manis JP, Tian M, Alt FW (2002) Mechanism and control of class-switch recombination. Trends Immunol 23:31–39PubMedCrossRefGoogle Scholar
  171. 171.
    Martensson IL, Keenan RA, Licence S (2007) The pre-B cell receptor. Curr Opin Immunol 19:137–142PubMedCrossRefGoogle Scholar
  172. 172.
    Martinez-Pomar N, Raga S, Ferrer J, Pons J, Munoz-Saa I, Julia MR, de Gracia J, Matamoros N (2006) Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-gamma gene. Clin Exp Immunol 144:233–238PubMedCrossRefGoogle Scholar
  173. 173.
    Martinez Garcia MA, de Rojas MD, Nauffal Manzur MD, Munoz Pamplona MP, Compte Torrero L, Macian V, Perpina Tordera M (2001) Respiratory disorders in common variable immunodeficiency. Respir Med 95:191–195PubMedCrossRefGoogle Scholar
  174. 174.
    McGeady SJ (1987) Transient hypogammaglobulinemia of infancy: need to reconsider name and definition. J Pediatr 110:47–50PubMedCrossRefGoogle Scholar
  175. 175.
    McKinney RE, Jr., Katz SL, Wilfert CM (1987) Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis 9:334–356PubMedGoogle Scholar
  176. 176.
    McQuaid A, Tormey VJ, Trafford B, Webster AD, Bofill M (2003) Evidence for increased expression of regulatory cytokine receptors interleukin-12R and interleukin-18R in common variable immunodeficiency. Clin Exp Immunol 134:321–327PubMedCrossRefGoogle Scholar
  177. 177.
    Mechanic LJ, Dikman S, Cunningham-Rundles C (1997) Granulomatous disease in common variable immunodeficiency. Ann Intern Med 127:613–617PubMedGoogle Scholar
  178. 178.
    Mellemkjaer L, Hammarstrom L, Andersen V, Yuen J, Heilmann C, Barington T, Bjorkander J, Olsen JH (2002) Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol 130:495–500PubMedCrossRefGoogle Scholar
  179. 179.
    Migone N, Oliviero S, de Lange G, Delacroix DL, Boschis D, Altruda F, Silengo L, DeMarchi M, Carbonara AO (1984) Multiple gene deletions within the human immunoglobulin heavy-chain cluster. Proc Natl Acad Sci U S A 81:5811–5815PubMedCrossRefGoogle Scholar
  180. 180.
    Minegishi Y, Coustan-Smith E, Wang YH, Cooper MD, Campana D, Conley ME (1998) Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia. J Exp Med 187:71–77PubMedCrossRefGoogle Scholar
  181. 181.
    Minegishi Y, Lavoie A, Cunningham-Rundles C, Bedard PM, Hebert J, Cote L, Dan K, Sedlak D, Buckley RH, Fischer A, Durandy A, Conley ME (2000) Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol 97:203–210PubMedCrossRefGoogle Scholar
  182. 182.
    Minegishi Y, Rohrer J, Coustan-Smith E, Lederman HM, Pappu R, Campana D, Chan AC, Conley ME (1999) An essential role for BLNK in human B cell development. Science 286:1954–1957PubMedCrossRefGoogle Scholar
  183. 183.
    Mullighan CG, Fanning GC, Chapel HM, Welsh KI (1997) TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J Immunol 159:6236–6241PubMedGoogle Scholar
  184. 184.
    Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102:553–563PubMedCrossRefGoogle Scholar
  185. 185.
    Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson NO, Honjo T (1999) Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 274:18470–18476PubMedCrossRefGoogle Scholar
  186. 186.
    Nathenson G, Schorr JB, Litwin SD (1971) Gm factor fetomaternal gamma globulin incompatibility. Pediatr Res 5:2–9CrossRefGoogle Scholar
  187. 187.
    Nijenhuis T, Klasen I, Weemaes CM, Preijers F, de Vries E, van der Meer JW (2001) Common variable immunodeficiency (CVID) in a family: an autosomal dominant mode of inheritance. Neth J Med 59:134–139PubMedCrossRefGoogle Scholar
  188. 188.
    Nonoyama S, Hollenbaugh D, Aruffo A, Ledbetter JA, Ochs HD (1993) B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. J Exp Med 178:1097–1102PubMedCrossRefGoogle Scholar
  189. 189.
    Notarangelo L, Casanova JL, Conley ME, Chapel H, Fischer A, Puck J, Roifman C, Seger R, Geha RS (2006) Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol 117:883–896PubMedCrossRefGoogle Scholar
  190. 190.
    Notarangelo L, Casanova JL, Fischer A, Puck J, Rosen F, Seger R, Geha R (2004) Primary immunodeficiency diseases: an update. J Allergy Clin Immunol 114: 677–687PubMedCrossRefGoogle Scholar
  191. 191.
    Notarangelo LD, Lanzi G, Peron S, Durandy A (2006) Defects of class-switch recombination. J Allergy Clin Immunol 117:855–864PubMedCrossRefGoogle Scholar
  192. 192.
    Notarangelo LD, Lanzi G, Toniati P, Giliani S (2007) Immunodeficiencies due to defects of class-switch recombination. Immunol Res 38:68–77PubMedCrossRefGoogle Scholar
  193. 193.
    Nourizadeh M, Aghamohammadi A, Moazzeni SM, Mahdavi M, Jalili A, Rezaei N, Hadjati J (2007) Altered dendritic cell function in response to sera of common variable immunodeficiency patients. Inflamm Res 56:527–532PubMedCrossRefGoogle Scholar
  194. 194.
    Nourizadeh M, Aghamohammadi A, Moazzeni SM, Mahdavi M, Rezaei N, Hadjati J (2007) High production of IL-18 by dendritic cells induced by sera from patients with primary antibody deficiency. Iran J Allergy Asthma Immunol 6:59–65PubMedGoogle Scholar
  195. 195.
    Ochs HD (2001) The Wiskott-Aldrich syndrome. Clin Rev Allergy Immunol 20:61–86PubMedCrossRefGoogle Scholar
  196. 196.
    Ochs HD, Fischer SH, Lee ML, Delson ES, Kingdon HS, Wedgwood RJ (1986) Intravenous immunoglobulin home treatment for patients with primary immunodeficiency diseases. Lancet 1:610–611PubMedCrossRefGoogle Scholar
  197. 197.
    Ochs HD, Gupta S, Kiessling P, Nicolay U, Berger M (2006) Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases. J Clin Immunol 26:265–273PubMedCrossRefGoogle Scholar
  198. 198.
    Ochs HD, Smith CI (1996) X-linked agammaglobulinemia. A clinical and molecular analysis. Medicine (Baltimore) 75:287–299CrossRefGoogle Scholar
  199. 199.
    Olerup O, Smith CI, Bjorkander J, Hammarstrom L (1992) Shared HLA class II-associated genetic susceptibility and resistance, related to the HLA-DQB1 gene, in IgA deficiency and common variable immunodeficiency. Proc Natl Acad Sci U S A 89:10653–10657PubMedCrossRefGoogle Scholar
  200. 200.
    Olsson PG, Gustafson R, Hammarstrom V, Lonnqvist B, Smith CI, Hammarstrom L (1993) Transfer by BMT of IgG2 deficiency involving an immunoglobulin heavy chain constant region deletion and a silent IgG2 gene. Bone Marrow Transplant 11:409–414PubMedGoogle Scholar
  201. 201.
    Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, Buckley R, Chinen J, El-Gamal Y, Mazer BD, Nelson RP, Jr., Patel DD, Secord E, Sorensen RU, Wasserman RL, Cunningham-Rundles C (2006) Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 117:S525–S553PubMedCrossRefGoogle Scholar
  202. 202.
    Oxelius VA, Laurell AB, Lindquist B, Golebiowska H, Axelsson U, Bjorkander J, Hanson LA (1981) IgG subclasses in selective IgA deficiency: importance of IgG2-IgA deficiency. N Engl J Med 304:1476–1477PubMedGoogle Scholar
  203. 203.
    Pan-Hammarstrom Q, Dai S, Zhao Y, van Dijk-Hard IF, Gatti RA, Borresen-Dale AL, Hammarstrom L (2003) ATM is not required in somatic hypermutation of VH, but is involved in the introduction of mutations in the switch mu region. J Immunol 170:3707–3716PubMedGoogle Scholar
  204. 204.
    Pan-Hammarstrom Q, Salzer U, Du L, Bjorkander J, Cunningham-Rundles C, Nelson DL, Bacchelli C, Gaspar HB, Offer S, Behrens TW, Grimbacher B, Hammarstrom L (2007) Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 39:429–430PubMedCrossRefGoogle Scholar
  205. 205.
    Pan Q, Hammarstrom L (2000) Molecular basis of IgG subclass deficiency. Immunol Rev 178:99–110PubMedCrossRefGoogle Scholar
  206. 206.
    Park JE, Beal I, Dilworth JP, Tormey V, Haddock J (2005) The HRCT appearances of granulomatous pulmonary disease in common variable immune deficiency. Eur J Radiol 54:359–364PubMedCrossRefGoogle Scholar
  207. 207.
    Pasquier B, Yin L, Fondaneche MC, Relouzat F, Bloch-Queyrat C, Lambert N, Fischer A, de Saint-Basile G, Latour S (2005) Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J Exp Med 201:695–701PubMedCrossRefGoogle Scholar
  208. 208.
    Petersen-Mahrt SK, Harris RS, Neuberger MS (2002) AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418:99–103PubMedCrossRefGoogle Scholar
  209. 209.
    Petersen S, Casellas R, Reina-San-Martin B, Chen HT, Difilippantonio MJ, Wilson PC, Hanitsch L, Celeste A, Muramatsu M, Pilch DR, Redon C, Ried T, Bonner WM, Honjo T, Nussenzweig MC, Nussenzweig A (2001) AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching. Nature 414:660–665PubMedCrossRefGoogle Scholar
  210. 210.
    Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, Yang K, Soudais C, Dupuis S, Feinberg J, Fieschi C, Elbim C, Hitchcock R, Lammas D, Davies G, Al-Ghonaium A, Al-Rayes H, Al-Jumaah S, Al-Hajjar S, Al-Mohsen IZ, Frayha HH, Rucker R, Hawn TR, Aderem A, Tufenkeji H, Haraguchi S, Day NK, Good RA, Gougerot-Pocidalo MA, Ozinsky A, Casanova JL (2003) Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299:2076–2079PubMedCrossRefGoogle Scholar
  211. 211.
    Piqueras B, Lavenu-Bombled C, Galicier L, Bergeron-van der Cruyssen F, Mouthon L, Chevret S, Debre P, Schmitt C, Oksenhendler E (2003) Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 23:385–400PubMedCrossRefGoogle Scholar
  212. 212.
    Plebani A, Duse M, Monafo V (1985) Recurrent infections with IgG2 deficiency. Arch Dis Child 60:670–672PubMedCrossRefGoogle Scholar
  213. 213.
    Plebani A, Soresina A, Rondelli R, Amato GM, Azzari C, Cardinale F, Cazzola G, Consolini R, De Mattia D, Dell’Erba G, Duse M, Fiorini M, Martino S, Martire B, Masi M, Monafo V, Moschese V, Notarangelo LD, Orlandi P, Panei P, Pession A, Pietrogrande MC, Pignata C, Quinti I, Ragno V, Rossi P, Sciotto A, Stabile A (2002) Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin Immunol 104:221–230PubMedCrossRefGoogle Scholar
  214. 214.
    Porpiglia AS, Rohrer J, Conley ME (2003) Reconstitution of B cell function in murine models of immunodeficiency. Clin Immunol 107:90–97PubMedCrossRefGoogle Scholar
  215. 215.
    Pourpak Z, Aghamohammadi A, Sedighipour L, Farhoudi A, Movahedi M, Gharagozlou M, Chavoshzadeh Z, Jadid L, Rezaei N, Moin M (2006) Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency. J Microbiol Immunol Infect 39:114–120PubMedGoogle Scholar
  216. 216.
    Quartier P, Bustamante J, Sanal O, Plebani A, Debre M, Deville A, Litzman J, Levy J, Fermand JP, Lane P, Horneff G, Aksu G, Yalcin I, Davies G, Tezcan I, Ersoy F, Catalan N, Imai K, Fischer A, Durandy A (2004) Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. Clin Immunol 110:22–29PubMedCrossRefGoogle Scholar
  217. 217.
    Quartier P, Debre M, De Blic J, de Sauverzac R, Sayegh N, Jabado N, Haddad E, Blanche S, Casanova JL, Smith CI, Le Deist F, de Saint Basile G, Fischer A (1999) Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr 134:589–596PubMedCrossRefGoogle Scholar
  218. 218.
    Rada C, Williams GT, Nilsen H, Barnes DE, Lindahl T, Neuberger MS (2002) Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr Biol 12:1748–1755PubMedCrossRefGoogle Scholar
  219. 219.
    Ramiro AR, Stavropoulos P, Jankovic M, Nussenzweig MC (2003) Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand. Nat Immunol 4:452–456PubMedCrossRefGoogle Scholar
  220. 220.
    Reichenberger F, Wyser C, Gonon M, Cathomas G, Tamm M (2001) Pulmonary mucosa-associated lymphoid tissue lymphoma in a patient with common variable immunodeficiency syndrome. Respiration 68:109–112PubMedCrossRefGoogle Scholar
  221. 221.
    Reina-San-Martin B, Difilippantonio S, Hanitsch L, Masilamani RF, Nussenzweig A, Nussenzweig MC (2003) H2AX is required for recombination between immunoglobulin switch regions but not for intra-switch region recombination or somatic hypermutation. J Exp Med 197:1767–1778PubMedCrossRefGoogle Scholar
  222. 222.
    Revy P, Busslinger M, Tashiro K, Arenzana F, Pillet P, Fischer A, Durandy A (2000) A syndrome involving intrauterine growth retardation, microcephaly, cerebellar hypoplasia, B lymphocyte deficiency, and progressive pancytopenia. Pediatrics 105:E39PubMedCrossRefGoogle Scholar
  223. 223.
    Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Catalan N, Forveille M, Dufourcq-Labelouse R, Gennery A, Tezcan I, Ersoy F, Kayserili H, Ugazio AG, Brousse N, Muramatsu M, Notarangelo LD, Kinoshita K, Honjo T, Fischer A, Durandy A (2000) Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102:565–575PubMedCrossRefGoogle Scholar
  224. 224.
    Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, Atarod L, Ghazi BM, Isaeian A, Mahmoudi M, Abolmaali K, Mansouri D, Arshi S, Tarash NJ, Sherkat R, Akbari H, Amin R, Alborzi A, Kashef S, Farid R, Mohammadzadeh I, Shabestari MS, Nabavi M, Farhoudi A (2006) Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol 26:519–532PubMedCrossRefGoogle Scholar
  225. 225.
    Rezaei N, Aghamohammadi A, Siadat SD, Moin M, Pourpak Z, Nejati M, Ahmadi H, Kamali S, Norouzian D, Tabaraei B, Read RC (2008) Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basia for clinical classification of common variable immunodeficiency. Clin Vaccine Immunol 15:607–611PubMedCrossRefGoogle Scholar
  226. 226.
    Rezaei N, Aghamohammadi A, Siadat SD, Nejati M, Ahmadi H, Moin M, Pourpak Z, Kamali S, Norouzian D, Tabaraei B, Read RC (2007) Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies. Vaccine 25:5308–5314PubMedCrossRefGoogle Scholar
  227. 227.
    Roifman CM (2004) Immunodeficiency Disorders: General Considerations. In: Stiehm ER, Ochs HD, Winkelstein JA (eds) Immunologic Disorders in Infants and Children. Elsevier Saunders, Philadelphia, pp 391–393Google Scholar
  228. 228.
    Roifman CM, Levison H, Gelfand EW (1987) High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinemia and chronic lung disease. Lancet 1:1075–1077PubMedCrossRefGoogle Scholar
  229. 229.
    Rudge P, Webster AD, Revesz T, Warner T, Espanol T, Cunningham-Rundles C, Hyman N (1996) Encephalomyelitis in primary hypogammaglobulinemia. Brain 119 (Pt 1):1–15PubMedCrossRefGoogle Scholar
  230. 230.
    Salzer U, Chapel HM, Webster AD, Pan-Hammarstrom Q, Schmitt-Graeff A, Schlesier M, Peter HH, Rockstroh JK, Schneider P, Schaffer AA, Hammarstrom L, Grimbacher B (2005) Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 37:820–828PubMedCrossRefGoogle Scholar
  231. 231.
    Salzer U, Maul-Pavicic A, Cunningham-Rundles C, Urschel S, Belohradsky BH, Litzman J, Holm A, Franco JL, Plebani A, Hammarstrom L, Skrabl A, Schwinger W, Grimbacher B (2004) ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol 113:234–240PubMedCrossRefGoogle Scholar
  232. 232.
    Sander CA, Medeiros LJ, Weiss LM, Yano T, Sneller MC, Jaffe ES (1992) Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol 16:1170–1182PubMedCrossRefGoogle Scholar
  233. 233.
    Sandler SG, Mallory D, Malamut D, Eckrich R (1995) IgA anaphylactic transfusion reactions. Transfus Med Rev 9:1–8PubMedCrossRefGoogle Scholar
  234. 234.
    Sawada A, Takihara Y, Kim JY, Matsuda-Hashii Y, Tokimasa S, Fujisaki H, Kubota K, Endo H, Onodera T, Ohta H, Ozono K, Hara J (2003) A congenital mutation of the novel gene LRRC8 causes agammaglobulinemia in humans. J Clin Invest 112:1707–1713PubMedGoogle Scholar
  235. 235.
    Schaffer AA, Salzer U, Hammarstrom L, Grimbacher B (2007) Deconstructing common variable immunodeficiency by genetic analysis. Curr Opin Genet Dev 17:201–212PubMedCrossRefGoogle Scholar
  236. 236.
    Schaffer FM, Monteiro RC, Volanakis JE, Cooper MD (1991) IgA deficiency. Immunodefic Rev 3:15–44PubMedGoogle Scholar
  237. 237.
    Schaffer FM, Palermos J, Zhu ZB, Barger BO, Cooper MD, Volanakis JE (1989) Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes. Proc Natl Acad Sci U S A 86:8015–8019PubMedCrossRefGoogle Scholar
  238. 238.
    Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M, Frew E, Scott ML (2001) An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293:2111–2114PubMedCrossRefGoogle Scholar
  239. 239.
    Schroeder HW, Jr. (2000) Genetics of IgA deficiency and common variable immunodeficiency. Clin Rev Allergy Immunol 19:127–140PubMedCrossRefGoogle Scholar
  240. 240.
    Schroeder HW, Jr., Schroeder HW, 3rd, Sheikh SM (2004) The complex genetics of common variable immunodeficiency. J Investig Med 52:90–103PubMedGoogle Scholar
  241. 241.
    Schroeder HW, Jr., Zhu ZB, March RE, Campbell RD, Berney SM, Nedospasov SA, Turetskaya RL, Atkinson TP, Go RC, Cooper MD, Volanakis JE (1998) Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes. Mol Med 4:72–86PubMedGoogle Scholar
  242. 242.
    Schur PH, Borel H, Gelfand EW, Alper CA, Rosen FS (1970) Selective gamma-g globulin deficiencies in patients with recurrent pyogenic infections. N Engl J Med 283:631–634PubMedGoogle Scholar
  243. 243.
    Scott-Taylor TH, Green MR, Eren E, Webster AD (2004) Monocyte derived dendritic cell responses in common variable immunodeficiency. Clin Exp Immunol 138:484–490PubMedCrossRefGoogle Scholar
  244. 244.
    Sediva A, Smith CI, Asplund AC, Hadac J, Janda A, Zeman J, Hansikova H, Dvorakova L, Mrazova L, Velbri S, Koehler C, Roesch K, Sullivan KE, Futatani T, Ochs HD (2007) Contiguous X-chromosome Deletion Syndrome Encompassing the BTK, TIMM8A, TAF7L, and DRP2 Genes. J Clin Immunol 27:640–646PubMedCrossRefGoogle Scholar
  245. 245.
    Sengupta S, Robles AI, Linke SP, Sinogeeva NI, Zhang R, Pedeux R, Ward IM, Celeste A, Nussenzweig A, Chen J, Halazonetis TD, Harris CC (2004) Functional interaction between BLM helicase and 53BP1 in a Chk1-mediated pathway during S-phase arrest. J Cell Biol 166:801–813PubMedCrossRefGoogle Scholar
  246. 246.
    Seymour B, Miles J, Haeney M (2005) Primary antibody deficiency and diagnostic delay. J Clin Pathol 58:546–547PubMedCrossRefGoogle Scholar
  247. 247.
    Shackelford PG, Polmar SH, Mayus JL, Johnson WL, Corry JM, Nahm MH (1986) Spectrum of IgG2 subclass deficiency in children with recurrent infections: prospective study. J Pediatr 108:647–653PubMedCrossRefGoogle Scholar
  248. 248.
    Shield JP, Strobel S, Levinsky RJ, Morgan G (1992) Immunodeficiency presenting as hypergammaglobulinaemia with IgG2 subclass deficiency. Lancet 340:448–450PubMedCrossRefGoogle Scholar
  249. 249.
    Siegel RL, Issekutz T, Schwaber J, Rosen FS, Geha RS (1981) Deficiency of T helper cells in transient hypogammaglobulinemia of infancy. N Engl J Med 305: 1307–1313PubMedCrossRefGoogle Scholar
  250. 250.
    Simons E, Spacek LA, Lederman HM, Winkelstein JA (2004) Helicobacter cinaedi bacteremia presenting as macules in an afebrile patient with X-linked agammaglobulinemia. Infection 32:367–368PubMedCrossRefGoogle Scholar
  251. 251.
    Sloper KS, Brook CG, Kingston D, Pearson JR, Shiner M (1981) Eczema and atopy in early childhood: low IgA plasma cell counts in the jejunal mucosa. Arch Dis Child 56:939–942PubMedCrossRefGoogle Scholar
  252. 252.
    Slyper AH, Pietryga D (1997) Conversion of selective IgA deficiency to common variable immunodeficiency in an adolescent female with 18q deletion syndrome. Eur J Pediatr 156:155–156PubMedGoogle Scholar
  253. 253.
    Smith CI, Hammarstrom L, Henter JI, de Lange GG (1989) Molecular and serologic analysis of IgG1 deficiency caused by new forms of the constant region of the Ig H chain gene deletions. J Immunol 142:4514–4519PubMedGoogle Scholar
  254. 254.
    Smith CI, Hammarstrom L, Lindahl M, Lockner D (1985) Kinetics of the spontaneously occurring common variable hypogammaglobulinemia: an analysis of two individuals with previously normal immunoglobulin levels. Clin Immunol Immunopathol 37:22–29PubMedCrossRefGoogle Scholar
  255. 255.
    Smith CI, Hammarstrom L, Palmblad J (1985) Development of a serologically complete IgA deficiency in a patient with common variable hypogammaglobulinemia. J Clin Lab Immunol 17:191–195PubMedGoogle Scholar
  256. 256.
    Sorensen RU, Leiva LE, Giangrosso PA, Butler B, Javier FC, 3rd, Sacerdote DM, Bradford N, Moore C (1998) Response to a heptavalent conjugate Streptococcus pneumonia vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine. Pediatr Infect Dis J 17:685–691PubMedCrossRefGoogle Scholar
  257. 257.
    Sorensen RU, Leiva LE, Javier FC, 3rd, Sacerdote DM, Bradford N, Butler B, Giangrosso PA, Moore C (1998) Influence of age on the response to Streptococcus pneumonia vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J Allergy Clin Immunol 102:215–221PubMedCrossRefGoogle Scholar
  258. 258.
    Sorensen RU, Moore C (1994) Immunology in the pediatrician’s office. Pediatr Clin North Am 41:691–714PubMedGoogle Scholar
  259. 259.
    Sorensen RU, Moore C (2000) Antibody deficiency syndromes. Pediatr Clin North Am 47:1225–1252PubMedCrossRefGoogle Scholar
  260. 260.
    Sorensen RU, Paris K (2006) Selective antibody deficiency with normal immunoglobulins (polysaccharide non-responses), Accessed at:
  261. 261.
    Stavnezer-Nordgren J, Kekish O, Zegers BJ (1985) Molecular defects in a human immunoglobulin kappa chain deficiency. Science 230:458–461PubMedCrossRefGoogle Scholar
  262. 262.
    Stavnezer J (2000) Immunology. A touch of antibody class. Science 288:984–985PubMedCrossRefGoogle Scholar
  263. 263.
    Stead A, Douglas JG, Broadfoot CJ, Kaminski ER, Herriot R (2002) Humoral immunity and bronchiectasis. Clin Exp Immunol 130:325–330PubMedCrossRefGoogle Scholar
  264. 264.
    Stewart DM, Tian L, Notarangelo LD, Nelson DL (2007) X-linked hypogammaglobulinemia and isolated growth hormone deficiency: an update. Immunol Res 38:391–399PubMedCrossRefGoogle Scholar
  265. 265.
    Strober W, Sneller MC (1991) IgA deficiency. Ann Allergy 66:363–375PubMedGoogle Scholar
  266. 266.
    Sundin U, Nava S, Hammarstrom L (1998) Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy. Clin Exp Immunol 112:341–346PubMedCrossRefGoogle Scholar
  267. 267.
    Tabatabaie P, Aghamohammadi A, Mamishi S, Isaeian A, Heidari G, Abdollahzade S, Pirouzi P, Rezaei N, Heidarnazhad H, MirSaeid Ghazi B, Yeganeh M, Cheraghi T, Saghafi S, Alizadeh H, Anaraki MR (2008) Evaluation of humoral immune function in patients with bronchiectasis. Iran J Allergy Asthma Immunol 7:69–77PubMedGoogle Scholar
  268. 268.
    Takada H, Kanegane H, Nomura A, Yamamoto K, Ihara K, Takahashi Y, Tsukada S, Miyawaki T, Hara T (2004) Female agammaglobulinemia due to the Bruton tyrosine kinase deficiency caused by extremely skewed X-chromosome inactivation. Blood 103:185–187PubMedCrossRefGoogle Scholar
  269. 269.
    Teahon K, Webster AD, Price AB, Weston J, Bjarnason I (1994) Studies on the enteropathy associated with primary hypogammaglobulinemia. Gut 35:1244–1249PubMedCrossRefGoogle Scholar
  270. 270.
    Teele DW, Klein JO, Word BM, Rosner BA, Starobin S, Earle R, Jr., Ertel CS, Fisch G, Michaels R, Heppen R, Strause NP (2000) Antimicrobial prophylaxis for infants at risk for recurrent acute otitis media. Vaccine 19 Suppl 1:S140–S143PubMedCrossRefGoogle Scholar
  271. 271.
    Thickett KM, Kumararatne DS, Banerjee AK, Dudley R, Stableforth DE (2002) Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. QJM 95:655–662PubMedCrossRefGoogle Scholar
  272. 272.
    Thieffrey S, Arthuis M, Aicardi J, Lyon G (1961) L’ataxie-telangiectasie (7 observations personnelles). Rev Neurol (Paris) 105:390–405Google Scholar
  273. 273.
    Tiller TL, Jr., Buckley RH (1978) Transient hypogammaglobulinemia of infancy: review of the literature, clinical and immunologic features of 11 new cases, and long-term follow-up. J Pediatr 92:347–353PubMedCrossRefGoogle Scholar
  274. 274.
    Timens W, Poppema S (1987) Impaired immune response to polysaccharides. N Engl J Med 317:837–839CrossRefGoogle Scholar
  275. 275.
    Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, Sparkes RS, Kubagawa H, Mohandas T, Quan S, et al. (1993) Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72:279–290PubMedCrossRefGoogle Scholar
  276. 276.
    Umetsu DT, Ambrosino DM, Geha RS (1986) Children with selective IgG subclass deficiency and recurrent sinopulmonary infection: impaired response to bacterial capsular polysaccharide antigens. Monogr Allergy 20:57–61PubMedGoogle Scholar
  277. 277.
    Umetsu DT, Ambrosino DM, Quinti I, Siber GR, Geha RS (1985) Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. N Engl J Med 313:1247–1251PubMedGoogle Scholar
  278. 278.
    Valiaho J, Smith CI, Vihinen M (2006) BTKbase: the mutation database for X-linked agammaglobulinemia. Hum Mutat 27:1209–1217PubMedCrossRefGoogle Scholar
  279. 279.
    van Kessel DA, van Velzen-Blad H, van den Bosch JM, Rijkers GT (2005) Impaired pneumococcal antibody response in bronchiectasis of unknown aetiology. Eur Respir J 25:482–489PubMedCrossRefGoogle Scholar
  280. 280.
    van Zelm MC, Reisli I, van der Burg M, Castano D, van Noesel CJ, van Tol MJ, Woellner C, Grimbacher B, Patino PJ, van Dongen JJ, Franco JL (2006) An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 354:1901–1912PubMedCrossRefGoogle Scholar
  281. 281.
    Vendrell M, de Gracia J, Rodrigo MJ, Cruz MJ, Alvarez A, Garcia M, Miravitlles M (2005) Antibody production deficiency with normal IgG levels in bronchiectasis of unknown etiology. Chest 127:197–204PubMedCrossRefGoogle Scholar
  282. 282.
    Verbruggen G, De Backer S, Deforce D, Demetter P, Cuvelier C, Veys E, Elewaut D (2005) X linked agammaglobulinaemia and rheumatoid arthritis. Ann Rheum Dis 64:1075–1078PubMedCrossRefGoogle Scholar
  283. 283.
    Vetrie D, Vorechovsky I, Sideras P, Holland J, Davies A, Flinter F, Hammarstrom L, Kinnon C, Levinsky R, Bobrow M, et al. (1993) The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361:226–233PubMedCrossRefGoogle Scholar
  284. 284.
    Vodjgani M, Aghamohammadi A, Samadi M, Moin M, Hadjati J, Mirahmadian M, Parvaneh N, Salavati A, Abdollahzade S, Rezaei N, Srrafnejad A (2007) Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications. J Investig Allergol Clin Immunol 17:321–328PubMedGoogle Scholar
  285. 285.
    Vorechovsky I, Blennow E, Nordenskjold M, Webster AD, Hammarstrom L (1999) A putative susceptibility locus on chromosome 18 is not a major contributor to human selective IgA deficiency: evidence from meiotic mapping of 83 multiple-case families. J Immunol 163:2236–2242PubMedGoogle Scholar
  286. 286.
    Vorechovsky I, Cullen M, Carrington M, Hammarstrom L, Webster AD (2000) Fine mapping of IGAD1 in IgA deficiency and common variable immunodeficiency: identification and characterization of haplotypes shared by affected members of 101 multiple-case families. J Immunol 164:4408–4416PubMedGoogle Scholar
  287. 287.
    Vorechovsky I, Webster AD, Plebani A, Hammarstrom L (1999) Genetic linkage of IgA deficiency to the major histocompatibility complex: evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition. Am J Hum Genet 64:1096–1109PubMedCrossRefGoogle Scholar
  288. 288.
    Vorechovsky I, Zetterquist H, Paganelli R, Koskinen S, Webster AD, Bjorkander J, Smith CI, Hammarstrom L (1995) Family and linkage study of selective IgA deficiency and common variable immunodeficiency. Clin Immunol Immunopathol 77:185–192PubMedCrossRefGoogle Scholar
  289. 289.
    Walker AM, Kemp AS, Hill DJ, Shelton MJ (1994) Features of transient hypogammaglobulinemia in infants screened for immunological abnormalities. Arch Dis Child 70:183–186PubMedCrossRefGoogle Scholar
  290. 290.
    Wang Y, Kanegane H, Sanal O, Tezcan I, Ersoy F, Futatani T, Miyawaki T (2002) Novel Igalpha (CD79a) gene mutation in a Turkish patient with B cell-deficient agammaglobulinemia. Am J Med Genet 108:333–336PubMedCrossRefGoogle Scholar
  291. 291.
    Wang Z, Yunis D, Irigoyen M, Kitchens B, Bottaro A, Alt FW, Alper CA (1999) Discordance between IgA switching at the DNA level and IgA expression at the mRNA level in IgA-deficient patients. Clin Immunol 91:263–270PubMedCrossRefGoogle Scholar
  292. 292.
    Warnatz K, Denz A, Drager R, Braun M, Groth C, Wolff-Vorbeck G, Eibel H, Schlesier M, Peter HH (2002) Severe deficiency of switched memory B cells (CD27(+) IgM(-) IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99:1544–1551PubMedCrossRefGoogle Scholar
  293. 293.
    Warnatz K, Salzer U, Gutenburger S, et al. (2004) Finally found: human BAF-R deficiency causes CVID. XIth Meeting of the European Society for ImmunodeficienciesGoogle Scholar
  294. 294.
    Washington K, Stenzel TT, Buckley RH, Gottfried MR (1996) Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol 20:1240–1252PubMedCrossRefGoogle Scholar
  295. 295.
    Wasserman RL, Sorensen RU (1999) Evaluating children with respiratory tract infections: the role of immunization with bacterial polysaccharide vaccine. Pediatr Infect Dis J 18:157–163PubMedCrossRefGoogle Scholar
  296. 296.
    Whelan MA, Hwan WH, Beausoleil J, Hauck WW, McGeady SJ (2006) Infants presenting with recurrent infections and low immunoglobulins: characteristics and analysis of normalization. J Clin Immunol 26:7–11PubMedCrossRefGoogle Scholar
  297. 297.
    Wiertsema SP, Veenhoven RH, Sanders EA, Rijkers GT (2005) Immunologic screening of children with recurrent otitis media. Curr Allergy Asthma Rep 5:302–307PubMedCrossRefGoogle Scholar
  298. 298.
    Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, Conley ME, Cunningham-Rundles C, Ochs HD (2006) X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) 85:193–202CrossRefGoogle Scholar
  299. 299.
    Yel L, Minegishi Y, Coustan-Smith E, Buckley RH, Trubel H, Pachman LM, Kitchingman GR, Campana D, Rohrer J, Conley ME (1996) Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N Engl J Med 335:1486–1493PubMedCrossRefGoogle Scholar
  300. 300.
    Yu K, Chedin F, Hsieh CL, Wilson TE, Lieber MR (2003) R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells. Nat Immunol 4:442–451PubMedCrossRefGoogle Scholar
  301. 301.
    Yu PW, Tabuchi RS, Kato RM, Astrakhan A, Humblet-Baron S, Kipp K, Chae K, Ellmeier W, Witte ON, Rawlings DJ (2004) Sustained correction of B cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer. Blood 104:1281–1290PubMedCrossRefGoogle Scholar
  302. 302.
    Zegers BJ, Maertzdorf WJ, Van Loghem E, Mul NA, Stoop JW, Van Der Laag J, Vossen JJ, Ballieux RE (1976) Kappa-chain deficiency. An immunoglobulin disorder. N Engl J Med 294:1026–1030PubMedCrossRefGoogle Scholar
  303. 303.
    Zhu Y, Nonoyama S, Morio T, Muramatsu M, Honjo T, Mizutani S (2003) Type two hyper-IgM syndrome caused by mutation in activation-induced cytidine deaminase. J Med Dent Sci 50:41–46PubMedGoogle Scholar
  304. 304.
    Zullo A, Romiti A, Rinaldi V, Vecchione A, Tomao S, Aiuti F, Frati L, Luzi G (1999) Gastric pathology in patients with common variable immunodeficiency. Gut 45:77–81PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • Asghar Aghamohmmadi
    • 1
  • Vassilios Lougaris
    • 2
  • Alessandro Plebani
    • 2
  • Toshio Miyawaki
    • 3
  • Anne Durandy
    • 4
  • Lennart Hammarström
    • 5
  1. 1.Division of Allergy and Clinical Immunology Children’s Medical Center HospitalTehran University of Medical SciencesTehranIran
  2. 2.Department of Pediatrics and Institute for Molecular Medicine “A. Nocivelli”University of BresciaBresciaItaly
  3. 3.Department of Pediatrics Faculty of MedicineToyama Medical and Pharmaceutical UniversityToyamaJapan
  4. 4.INSERM U768Hôpital Necker-Enfants MaladesParisFrance
  5. 5.Division of Clinical Immunology Department of Laboratory MedicineKarolinska InstituteStockholmSweden

Personalised recommendations